Salute e Benessere

IPSEN - Buy-back programme - Art 5 of MAR - Week 47 - 2025

Aggregated presentation by day and by marketStatement of transactions in own shares from November 17th to November 21st 2025 Name of the issueIdentity code of the issuer(Legal Entity Identifier) Day of the transactionIdentity code of the financial instrument Total daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code)IPSEN549300M6SGDPB4Z94P1117/11/2025FR0010259150 ...
Nasdaq GlobeNewswire
25/11/2025

Oxurion Receives Transparency Notification from Atlas Special Opportunities II…

Leuven, BELGIUM – November 25, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on November 25, 2025, from Atlas Special Opportunities…
Actusnews Wire
25/11/2025

Pediatric Vascular Access Market worth US$833.1 million by 2030 with 7.4% CAGR |…

Browse in-depth TOC on "Pediatric Vascular Access Market" Browse in-depth TOC on "Pediatric Vascular Access Market" 160 - Tables 50 - Figures 300 - Pages By type,the Pediatric Vascular Access market is segmented into catheters, implantable ports, port needles, catheter securement and stabilization, catheter caps & closures, vascular closure devices, IV connectors, syringes and needles, infusion pumps, IV sets & accessories, intraosseous infusion devices, anesthesia...
PR Newswire
25/11/2025

Office Furniture Market Growth Led by Asia Pacific, B2B/Direct Sales Segment…

Asia-Pacific Asia-Pacific Asia-Pacificdominates the office furniture market, driven by expanding office developments, skilled labor availability, and supportive investment inflows. Countries such asIndiaandVietnamare witnessing rapid growth in workspace construction, while sustainability initiatives and the use of eco-friendly materials like recycled panels and low-emission coatings continue to strengthen market momentum. North America North Americaremains a...
PR Newswire
25/11/2025

Dietary Supplements Market to Hit $414.5B by 2033, Growing at 8.9% CAGR - Key…

In addition, the increasing adoption of personalized nutrition, driven by advancements in nutrigenomics and digital health technologies, is reshaping consumer preferences. The market is witnessing demand for targeted supplements that support gut health, cognitive function, stress management, hormonal balance, and overall well-being. Millennials, in particular, show strong interest in supplements with probiotics, nootropics, adaptogens, and herbal extracts. In addition, the increasing adoption...
PR Newswire
25/11/2025

Innova Therapeutics to Advance Novel Cancer Treatment with Enci Therapeutics…

MT PLEASANT, S.C., Nov. 25, 2025 /PRNewswire/ -- Innova Therapeutics, a biopharmaceutical company, has announced that it has completed the acquisition of Enci Therapeutics. The acquisition includes Enci Therapeutics' main cancer therapeutic program, IVT-8086. The specific terms of the agreement and financial details regarding the acquisition between Innova Therapeutics and Enci Therapeutics have not been disclosed. MT PLEASANT, S.C. , Nov. 25, 2025 /PRNewswire/ -- Innova Therapeutics, a...
PR Newswire
25/11/2025

Veterinary Reference Laboratory Market worth US$6.46 billion by 2030 with 6.3%…

The veterinary reference laboratory market is witnessing rapid technological advancement driven by innovation in diagnostic methodologies, automation, and molecular testing. Market participants are increasingly focusing on developing advanced diagnostic panels, integrating AI-driven data analysis, and expanding assay menus to enhance accuracy, efficiency, and turnaround time. The adoption of next-generation sequencing (NGS), PCR-based diagnostics, immunodiagnostics, and high-throughput analyzers…
PR Newswire
25/11/2025

VINNO Showcases "Sound, Light, and Air" Integration at MEDICA 2025 -- Global…

VINNO's ULTIMUS platform continues to show how far ultrasound can go. Powered by Ultra-Resolution Microscopy (URM), it captures microvascular details that standard imaging simply cannot see. VINNO's ULTIMUS platform continues to show how far ultrasound can go. Powered by Ultra-Resolution Microscopy (URM), it captures microvascular details that standard imaging simply cannot see. This capability is gaining clinical momentum inEurope, where institutions like University Hospital Erlangen are...
PR Newswire
25/11/2025

Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into…

TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that its Phase 2 clinical trial evaluating intranasal foralumab in patients with amyotrophic lateral sclerosis (ALS) has been accepted for inclusion in the ALS MyMatch Program at the Sean M. Healey & AMG Center for ALS at Mass General Brigham.The study, supported by a grant from the ALS Association, will be led by Principal Investigators Suma Babu, MBBS, MPH,...
Nasdaq GlobeNewswire
25/11/2025

Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar…

Following the positive opinions of the Committee for Medicinal Products for Human Use (CHMP ), the European Commission has granted marketing authorizations for Teva’s biosimilars PONLIMSI and DEGEVMA expanding access to important bone health treatments across Europe These approvals mark another significant milestone in Teva’s strong biosimilars portfolio, in line with Teva's Pivot to Growth StrategyThe approvals underscore Teva’s commitment to broadening access to biosimilars...
Nasdaq GlobeNewswire
25/11/2025

Elton John AIDS Foundation and Zipline: $150M US State Department Boost…

Impact Since EJAF's 2023 Support Impact Since EJAF's 2023 Support Kenya&Nigeriaat a glance "From the beginning, the Elton John AIDS Foundation has stood with communities too often left behind, without the healthcare they urgently need and deserve," saidElton John, Founder of the Elton John AIDS Foundation. "Zipline's innovative approach to delivering medical care is exactly the kind of work our Foundation exists to champion. We were their first philanthropic partner in...
PR Newswire
25/11/2025

Avicenna.AI Joins Forces with Ferrum Health to Expand U.S. Access to Advanced…

Ferrum's suite gives clinicians access to advanced AI technologies designed to enhance diagnostic accuracy across oncology, women's and men's health, cardiovascular care, neurology, orthopedics, and more. By adding Avicenna's emergency and high-impact imaging solutions to its expanding library, Ferrum strengthens its position as one of the most comprehensive AI marketplaces in healthcare. Ferrum's suite gives clinicians access to advanced AI technologies designed to enhance diagnostic…
PR Newswire
25/11/2025

Bulat Utemuratov Foundation's autism program wins prestigious AmCham healthcare…

Launched in 2015, the program operates 13 Asyl Miras autism centers in 12 cities across Kazakhstan. It offers free services that combine the expertise of psychologists, speech therapists, and behavioral analysts using internationally recognized evidence-based methods including ABA therapy, JASPER, the Early Childhood Intervention Model, and MCRR crisis management. Over the past decade, more than 17,000 children and their families have received support, while over 300 specialists have been…
PR Newswire
25/11/2025

Amphista Therapeutics announces new AMX-883 data to be presented at the ASH…

AMX-883 shows synergistic efficacy in combination with venetoclax in vivoand prevents the emergence of resistance to venetoclaxin vitro, addressing a major clinical challenge in acute myeloid leukaemia (AML)AMX-883 showed a significant survival benefit and reduced disease burden compared to control treatments, while being well tolerated in a murine pre-clinical experimentData provides compelling evidence of BRD9's critical role in AML and supports progression of AMX-883, as a...
Nasdaq GlobeNewswire
25/11/2025

Pet Biotics Market worth $1,232.5 million by 2030- Exclusive Report by…

Browse in-depth TOC on "Pet Biotics Market" Browse in-depth TOC on "Pet Biotics Market" 250– Tables 50– Figures 290– Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=89829007 The probiotics product type segment is expected to hold the highest market share during the forecast period Probiotics are expected to hold the highest market share in the pet biotics market during the forecast period, driven by their well-established...
PR Newswire
25/11/2025

Novo Nordisk phase 2 trial with amycretin reports significant weight loss and…

Amycretin showed statistically significant weight loss of up to 14.5% at 36 weeksAmycretin demonstrated statistically significant reductions in HbA 1cwith up to 89.1% achieving HbA 1clevels below 7%Amycretin appeared to have a safe and well-tolerated profile consistent with incretin and amylin-based therapiesBagsværd, Denmark, 25 November 2025– Novo Nordisk today announced positive headline results from a phase 2 clinical trial with amycretin in people with type 2 diabetes...
Nasdaq GlobeNewswire
25/11/2025

Catalyx Report Reveals Persistent Manufacturing Bottlenecks in Life Sciences…

The 2025 Life Sciences Line Clearance Benchmark Report from Catalyx, a leader in automation and vision system integration for highly regulated industries, found that most pharmaceutical, medical device, and contract development organizations continue to engage traditional manual methods for production line changeovers despite mounting evidence of their operational inefficiencies. The 2025 Life Sciences Line Clearance Benchmark Report from Catalyx, a leader in automation and vision system...
PR Newswire
25/11/2025

Zelluna ASA – Extraordinary General Meeting held on November 25, 2025

Oslo, November 25, 2025:Zelluna ASA held its extraordinary general meeting today November 25, 2025. All the matters on the agenda were approved. The minutes from the meeting are enclosed and available at the company’s website.For further information, please seewww.zelluna.comor contact: Anders Tuv, Chairman of the Board of Directors of Zelluna ASAEmail: at@radforsk.noPhone: +47 982 06 826 Namir Hassan, CEO, Zelluna ASAEmail: namir.hassan@zelluna.comPhone: +44 7720...
Nasdaq GlobeNewswire
25/11/2025

Generic Drugs Market Size to Worth USD 898 Billion by 2035, at a CAGR of 5.75% |…

Generic Drugs Market Enters a High-Momentum, Affordability-First Era Generic Drugs Market Enters a High-Momentum, Affordability-First Era Major trends reshaping the global generics landscape include: The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.vantagemarketresearch.com/generic-drugs-market-1660/request-sample Free Sample Includes: Why CXOs Are Focusing on the Generic Drugs Opportunity Key Market...
PR Newswire
25/11/2025

Hisense Showcases Smart and Sustainable HVAC Innovations at The Big 5 Global

On display are Rooftop Units, Fresh Air Handling Units (FAHU), Fan Coil Units, Floor Standing Units, Wall Mounted Units in both black and white panels, Touch Controllers, Central and Wired Controllers, and Energy Storage Systems. On display are Rooftop Units, Fresh Air Handling Units (FAHU), Fan Coil Units, Floor Standing Units, Wall Mounted Units in both black and white panels, Touch Controllers, Central and Wired Controllers, and Energy Storage Systems. "At The Big 5 this year, Hisense…
PR Newswire
25/11/2025

Biocomposites announces expanded approval for STIMULAN® Rapid Cure to be mixed…

KEELE, England, Nov. 25, 2025 /PRNewswire/ -- Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, today announces it has gained an expanded approval in India for STIMULAN® Rapid Cure. The approval from India's Central Drugs Standard Control Organisation (CDSCO) allows STIMULAN® Rapid Cure to be mixed with a wider variety of antibiotics than before, including in…
PR Newswire
25/11/2025

RefluxStop® 'Best in Class' at Japan Foregut Conference as 5-Year Data and…

Key Data Presentations: Key Data Presentations: "The significant increase in the prevalence of GERD inJapanis driving both interest and the need for a solution like RefluxStop, that addresses the true cause of the disease, an anatomical failure of the body's natural anti-reflux barrier," said Prof. Yano, Jikei University, Tokyo Dr.Peter Forsell, CEO and Founder of Implantica, expressed his gratitude and highlighted the significance of the Japanese market. "We are incredibly...
PR Newswire
25/11/2025

RAMSAY SANTE : Press release on November 25 2025

PRESS RELEASE Paris, 25 thNovember 2025 Update on Ramsay Health Care Limited's review of its strategic options associated with its majority shareholding in Ramsay Générale de Santé On 27 February 2025, Ramsay Générale de Santé acknowledged the announcement of its Australian reference shareholder Ramsay Health Care Limited regarding the review of its strategic options associated with its majority shareholding in Ramsay Générale de Santé.Today, Ramsay...
Nasdaq GlobeNewswire
25/11/2025

Novartis data underscore pioneering scientific innovation in Hematology and…

Positive results from ianalumab pivotal Phase III trial in ITP patients previously treated with corticosteroids to be presented as late-breakerScemblix data across clinical and real-world settings offer new evidence informing CML care amid evolving patient needs 96-week pelabresib Phase III data represent longest follow-up of first-line myelofibrosis patients in randomized combination trialKisqali NATALEE and MONALEESA data add to evidence of long-term benefits for early...
Nasdaq GlobeNewswire
25/11/2025
Altri  Comunicati